Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Pharmaceutical Technology
JUNE 27, 2025
Porton Advanced will apply its knowledge in viral vector technology and CAR-T cell therapy process development to enhance EVA Pharma’s mission to provide safe, effective, and scalable cancer treatments. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Let's personalize your content